carbamylhydrazine has been researched along with Metabolic Diseases in 1 studies
carbamylhydrazine: RN given refers to parent cpd
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Owing to the parallelism between the in vitro insulin mimicry and the in vivo improvement of glucose handling elicited by benzylamine in rodents, the SSAO/VAP-1 substrates, with stronger effects on human adipocytes than benzylamine, show promising applications for the treatment of insulin resistance." | 3.76 | SSAO substrates exhibiting insulin-like effects in adipocytes as a promising treatment option for metabolic disorders. ( Attané, C; Balogh, B; Brenachot, X; Carpéné, C; Dunkel, P; Földi, A; Iffiú-Soltesz, Z; Mátyus, P; Mercader, J; Valet, P, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mercader, J | 1 |
| Iffiú-Soltesz, Z | 1 |
| Brenachot, X | 1 |
| Földi, A | 1 |
| Dunkel, P | 1 |
| Balogh, B | 1 |
| Attané, C | 1 |
| Valet, P | 1 |
| Mátyus, P | 1 |
| Carpéné, C | 1 |
1 other study available for carbamylhydrazine and Metabolic Diseases
| Article | Year |
|---|---|
SSAO substrates exhibiting insulin-like effects in adipocytes as a promising treatment option for metabolic disorders.
Topics: 3T3 Cells; Adipocytes; Adipokines; Amine Oxidase (Copper-Containing); Animals; Apelin; Benzylamines; | 2010 |